Description
Hello, I need the presentation and speech for my Business Policy class. It is 5-minute pitch about “Company’s unicorn”. I will send my previous presentation. My unicorn for this pitch is: Prime Medicine company (i took this company from this site
https://pitchbook.com/news/articles/unicorn-startups-list-trends)
Your 5-minute pitch should include:
Reminder of the industry you presented
Description of your unicorn — what it does, who funds it, its target market
EC: estimated TAM or international competitive strategy
What problem it is solving and its unique value proposition
The top two value drivers and top two cost drivers for your unicorn
Where you think it sits in Porter’s model of competitive strategies.
Here’s what your grade will be based on:
Knowledge of the company and its business model (30%)
Depth/accuracy of discussion of the required elements in the previous bullet (40%)
Professionalism: Reference sources in your comments as well as on the slides, No typos or GSP errors in your slides, One chart per slide, Follow the rule of 7, Easy-to-read, attractive slides with clear graphics relevant to making your points, Tell me how you used AI to build your pitch
Unformatted Attachment Preview
Which industry would
be good to invest in for
the next 10 years
MARIIA KOROLEVA
By 2030, 170 million
of American people
are expected to
suffer from at least
one chronic illness
By 2030, 21%
of US
population will
be age 65+
▪By 2033, fifth of US will be age 65+
▪According to NCOA research, 94.9%
present of adults age 60 and older have
at least one chronic condition, while
78.7% have two or more
Investment: Biochemistry in healthcare
It is projected that over a third of the U.S. population will be older resulting in
greater demand for health care services and novel medications.
Behavioral, for instance healthier lifestyle trends by the consumer match in well
with biochemistry’s healthcare sector.
The transition into preventive healthcare contributes to a large consumer market
for advanced medications and treatment approaches.
The biochemistry healthcare industry is poised to meet these emerging needs.”
Source: Valles, S. (2020). Philosophy of biomedicine.
Five sources analysis
Buyer Power
Supplier effect
• Suppliers have medium
bargaining power
• Close ties provide better
negotiating deals
Threat of new entry
•
•
High capital, regulatory licenses, and
expertise required
Competitive
Rivalry
• Presence of established
pharmaceutical companies
• Growth in R&D, and patent
expirations drive
competition
• CAGR: >13.5%
Established players with strong
intellectual property rights limiting
new entrants
Sources: Biotechnology Market Size, Share, Growth, Forecast 2021-2030
•
Insurance and health policies
provide opportunity to acquire
treatment
•
Bargaining power constrained
by need for medicine and
healthcare services
Threat of Substitution
+ Most medications have no
substitutes
– New treatment methods such as
CAM pose threat
Ways to invest
Allocate
Support
Fund
Diversify
Allocate Capital to
Pharmaceutical
Stocks: Invest $$ to
existing
pharmaceutical
firms that have
proved themselves
in terms of
innovation and
growth.
Support Biotech
Startups: Spend $$
on promising
biotech startups.
Fund Research &
Development Bonds:
Spend $$ of the R&D
bonds that support
biochemistry and
healthcare projects.
Diversify with
Healthcare ETFs:
Diversify across the
biochemistry and
healthcare assets by
investing $$ in
healthcare ETFs.
Sources: Biotechnology Market Size, Share, Growth, Forecast 2021-2030
Preserving Health, Growing
Wealth:
The Biochemistry Investment
Advantage.
References
▪Wu, Shin-Yi et al.2000. Projection of Chromic Illness Prevalence and Cost
Inflation. RAND Corporation.
▪U.S. Census Bureau, 2017 National Population Projection.
▪National Population Projection, 2017 www.census.gov/programssurveys/popproj.html
▪Valles, S. (2020). Philosophy of biomedicine.
▪Biotechnology Market Size, Share, Growth, Forecast 2021-2030
Purchase answer to see full
attachment
